Table of Contents Why GLP-1 Medications Cause Bloating Glucagon-like peptide-1 (GLP-1) receptor agonists including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Saxenda, Victoza) are increasingly prescribed for type 2 diabetes management and weight loss
A recent cohort study involving 200 IBD patients identified visceral adiposity, rather than BMI, as a predictive risk factor for a shorter time to IBD flare, particularly for CD patients (90)
Eat slowly, stop when full, and avoid lying down immediately after eating
Hayashi, N., Iida, T., et al
Clinical Evidence: Frequency, Timing, and Risk Factors Published data on semaglutide-associated chills remains limited but growing
According to him, tracking, monitoring, and optimizing this risk reduction is critical to reducing the complications of cardiovascular-kidney-metabolic disease. However, as with other GLP-1 receptor agonists, orforglipron carries safety considerations